Field-based, Waltham, MA - 2 openings
Our client is seeking a scientifically driven
Business Development Manager to help identify and advance strategic licensing and partnership opportunities for its industry-leading antibody discovery platform. This is an outstanding opportunity for a Ph.D.-level scientist with expertise in early antibody discovery who is interested in applying their scientific knowledge in a business-facing role. Working closely with cross-functional teams and external partners, you'll help evaluate new opportunities, support licensing initiatives, and contribute to the growth of the companys global partnerships.
Responsibilities:- Establish external business opportunities for out-licensing, co-development, and other structured transactions
- Lead the development and presentation of business cases of prioritized external opportunities with recommendations to management team with robust analyses, key assumptions, and risks, as well as internal and external input where necessary
- Initiate, lead and present external opportunities with limited supervision
- Lead driving cross-functional due diligence and alliance management, coordinate with R&D, CMC, Clinical, Regulatory, Operations, and Finance and executive reporting, in some instances be the main BD contact person
- Follow BD operations and transactions including proposals and TS developments, negotiations, deal closure and alliance management
- Contribute to the definition and revision of business development & licensing strategy that is in line with overall corporate and portfolio strategies
- Represent company at industry, investor and partnering conferences, develop and maintain relationships with a wide range of pharmaceutical/biotechnology industry participants
Requirements:- Ph.D. in pharmacology, immunology, cancer biology, or a related biomedical science field
- Strong background in antibody drug discovery, with a deep understanding of target validation and hit-to-lead optimization
- Proven ability to interpret complex biological data (affinity, specificity, and in vivo efficacy) and translate it into a compelling therapeutic and licensing narrative
- Familiarity with current antibody modalities, including monoclonal antibodies (mAbs), bispecific antibodies, and ADCs
- Strong strategic thinking skills to align internal scientific platform capabilities with pharmaceutical partner pipeline gaps
- Mandarin and English bilingual, to effectively bridge global R&D and business communications